- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04261062
Validity Test of Wearable Continuous Blood Pressure Measuring System
July 21, 2020 updated by: Yonsei University
- Purpose of Research For the feasibility test of a wearable blood pressure measuring device, biometric data of patients in surgical intensive care is simultaneously obtained and stored from the device and a patient monitor.
- Overview of Research Design This research is simply to obtain and store the data: 1) invasive arterial blood pressure measured with a patient monitor from one wrist, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device from the other wrist.
- Medical Device for Clinical Trial Patient monitor (IntelliVue MX700, Philips, NED) and wearable blood pressure measuring device
- Target Recruiting Number of Participants Considering the expected patient number in intensive care and 10% dropout rate during the research period, the target recurring number of participants is 220.
Criteria of Participant Inclusion
- Adult patient in surgical intensive care of Severance Hospital
- Voluntarily agreed to participate the research and not included to the exclusion criteria
Criteria of Participant Exclusion
- Patient with occlusive peripheral arterial disease
- Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
- Patient administered high-dose of pressor agent over 15 mcg/min
- Patient who is not available for measurement of invasive arterial blood pressure
- Patient who is not available to wear an wearable device on the wrist
- Pregnant woman, minor
Evaluation Parameter
- Systolic and diastolic blood pressure, which extracted in mmHg unit from the continuous blood pressure output of patient monitor.
- Blood pressure, which estimated by the signal analysis of multi-wavelength photoplethysmography and pressure signal measured with the wearable device.
Data Analysis and Statistical Methods
- From the multi-wavelength photoplethysmography and multi-channel pressure signal measured, continuous blood pressure will be estimated through the hemodynamic model and machine learning model.
- For the machine learning model, the data obtained will be divided into the training data and evaluation data, with the ratio of 80% and 20%.
- In order to evaluate the accuracy of the estimated blood pressure, the invasive arterial blood pressure will be considered as the reference blood pressure. Between the estimated blood pressure and the reference blood pressure, the correlation and root mean square error (RMSE) will be calculated.
Study Overview
Status
Unknown
Conditions
Detailed Description
- Recruit participants.
- Explain the research purpose and details, and then have the participant sign the consent form.
- Before starting the measurement, gather the participant's information such as age, length, and weight.
- Measure noninvasive blood pressure in both arms. Compared to the blood pressure in the arm where inserted a catheter, confirm if difference of systolic or diastolic blood pressure in the other side of arm is not more than 10%.
- Wear the wearable device on the opposite wrist from the catheter-inserted.
- For 10 minutes, simultaneously obtain the data: 1) invasive arterial blood pressure measured with a patient monitor, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device.
- For accuracy of data acquisition, repeat twice the procedure 5-7 by performing it in the morning and in the afternoon with the 5 hours interval.
Study Type
Observational
Enrollment (Anticipated)
220
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Yonsei University College of Medicine, Department of Anesthesiology and Pain Medicine
-
Contact:
- Jeongmin Kim
- Phone Number: 82-2-2227-3569
- Email: anesjeongmin@yuhs.ac
-
Principal Investigator:
- Jeongmin Kim
-
Sub-Investigator:
- KwanHyung Kim
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients in surgical intensive care
Description
Inclusion Criteria:
- Adult patient in surgical intensive care of Severance Hospital
- Voluntarily agreed to participate the research and not included to the exclusion criteria
Exclusion Criteria:
- Patient with occlusive peripheral arterial disease
- Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
- Patient administered high-dose of pressor agent over 15 mcg/min
- Patient who is not available for measurement of invasive arterial blood pressure
- Patient who is not available to wear an wearable device on the wrist
- Pregnant woman, minor
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Subject
Patients in surgical intensive unit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Title quality of pulsewave
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
User Comfortability
Time Frame: 2 years
|
Abnormal symptoms or discomforts reported in wearing device
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.
- Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology. 2005 Aug;103(2):419-28; quiz 449-5. doi: 10.1097/00000542-200508000-00026.
- Hughes DJ, Babbs CF, Geddes LA, Bourland JD. Measurements of Young's modulus of elasticity of the canine aorta with ultrasound. Ultrason Imaging. 1979 Oct;1(4):356-67. doi: 10.1177/016173467900100406. No abstract available.
- Liu J, Yan BP, Dai WX, Ding XR, Zhang YT, Zhao N. Multi-wavelength photoplethysmography method for skin arterial pulse extraction. Biomed Opt Express. 2016 Sep 27;7(10):4313-4326. doi: 10.1364/BOE.7.004313. eCollection 2016 Oct 1.
- Guanqun Zhang, Cottrell AC, Henry IC, McCombie DB. Assessment of pre-ejection period in ambulatory subjects using seismocardiogram in a wearable blood pressure monitor. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:3386-3389. doi: 10.1109/EMBC.2016.7591454.
- Corino VD, Lombardi F, Mainardi LT. Blood pressure variability in patients with atrial fibrillation. Auton Neurosci. 2014 Oct;185:129-33. doi: 10.1016/j.autneu.2014.08.002. Epub 2014 Aug 17.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 7, 2020
Primary Completion (Anticipated)
January 1, 2022
Study Completion (Anticipated)
January 1, 2022
Study Registration Dates
First Submitted
February 6, 2020
First Submitted That Met QC Criteria
February 6, 2020
First Posted (Actual)
February 7, 2020
Study Record Updates
Last Update Posted (Actual)
July 23, 2020
Last Update Submitted That Met QC Criteria
July 21, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 1-2019-0080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients in Surgical Intensive Care
-
Claudia SpiesCompletedSedation in Intensive Care Unit PatientsGermany
-
Hospices Civils de LyonUnknownIntubated Patients | Admission in Intensive Care UnitFrance
-
Centre Hospitalier Universitaire DijonCompletedIntubated-ventilated Patients in the Intensive Care UnitFrance
-
Sakarya UniversityEge UniversityCompletedAssessment of Oral Health Status of Patients in Pediatric Intensive Care UnitsTurkey
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingIntensive Care PatientsFrance
-
Hospital NordUnknownIntensive Care, SurgicalFrance
-
Oslo University HospitalUniversity of Copenhagen; University of California, San Francisco; South-Eastern...Completed
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
-
B. Braun Melsungen AGCompletedIntensive Care PatientsUnited Kingdom, Estonia, Denmark, Germany, Poland, Czech Republic, Italy, Spain, Sweden
-
Taipei Veterans General Hospital, TaiwanCompletedIntensive Care Unit PatientsTaiwan